Senaste försöken

EudraCT Number: 2005-004009-26 Sponsor Protocol Number: E7389-G000-301 Start Date: 2006-11-27
Sponsor Name: Eisai Limited
Full Title: A Phase III Open Label, Randomized Two-Parallel-Arm Multicenter Study of E7389 versus Capecitabine in Patients with Locally Advanced or Metastatic Breast Cancer Previously Treated with Anthracyclin...
Medical condition: Locally advanced or metastatic breast cancer
Disease: Version SOC Term Classification Code Term Level
8.1 10055113 PT
Population Age: Adults, Elderly Gender: Female
Trial protocol: HU (Completed) BE (Completed) CZ (Completed) LT (Completed) DE (Completed) FR (Completed) IT (Prematurely Ended) GR (Completed) BG (Completed) ES (Completed)
Trial results: View results
EudraCT Number: 2006-001434-41 Sponsor Protocol Number: NH20052 Start Date: 2006-11-27
Sponsor Name: F. Hoffmann-La Roche Ltd
Full Title: An open-label, randomized, multicenter, parallel group study to demonstrate correction of anemia using once every four week subcutaneous injections of RO0503821 in patients with chronic kidney dise...
Medical condition: Chronic renal anemia
Disease: Version SOC Term Classification Code Term Level
8.1 10058124 Nephrogenic anemia LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Completed) FR (Completed) SE (Prematurely Ended) GR (Completed) IT (Completed) BE (Completed) HU (Completed) ES (Completed)
Trial results: View results
EudraCT Number: 2006-003821-10 Sponsor Protocol Number: ML20681 Start Date: 2006-11-27
Sponsor Name: Roche Farma, S.A.
Full Title: Estudio aleatorizado, abierto y cruzado para evaluar la tolerabilidad del dispositivo de inyección sin aguja B2000 para la administración de enfuvirtida.
Medical condition: Infección por el VIH, no especificada
Disease: Version SOC Term Classification Code Term Level
14.1 10021881 - Infections and infestations 10020441 Human immunodeficiency virus infection, unspecified LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: ES (Ongoing)
Trial results: (No results available)
EudraCT Number: 2006-004710-41 Sponsor Protocol Number: AMLBFM0401 Start Date: 2006-11-26
Sponsor Name: St. Anna Kinderkrebsforschung
Full Title: Multizentrische Therapieoptimierungsstudie AML-BFM 2004 zur Behandlung der akuten myeloischen Leukämien bei Kindern und Jugendlichen Multicentric therapy optimizing study AML-BFM 2004 for the trea...
Medical condition: For acute myeloic leukaemia in children and juveniles improvment of treatment with new medications should be investigated: 1. Cladribine: originally licenced for hairy cell leukamia has shown good ...
Disease: Version SOC Term Classification Code Term Level
8.1 10001941 AML LLT
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 Gender: Male, Female
Trial protocol: AT (Completed)
Trial results: View results
EudraCT Number: 2006-002698-38 Sponsor Protocol Number: ALS-03-05-P-301 Start Date: 2006-11-24
Sponsor Name: Air Liquide Sante International
Full Title: STUDY OF THE EFFICACY AND SAFETY OF KALINOX® 170 BAR FOR THE PERFORMANCE OF CARE PROCEDURES IN CHILDREN WITH BURNS
Medical condition: Study of the efficacy and tolerance of Kalinox 170 bar for the performance of care procedures in children with burn.
Disease: Version SOC Term Classification Code Term Level
Population Age: Children, Under 18 Gender:
Trial protocol: BE (Ongoing) ES (Ongoing)
Trial results: (No results available)
EudraCT Number: 2004-001557-29 Sponsor Protocol Number: A2171035 Start Date: 2006-11-24
Sponsor Name: Pfizer Inc.
Full Title: A 52-WEEK MULTICENTER, OPEN-LABEL, RANDOMIZED, PARALLEL, TWO - ARM STUDY COMPARING EXUBERA® (INHALED HUMAN INSULIN) VS. HUMALOG® (INSULIN LISPRO), BOTH IN COMBINATION WITH INSULIN GLARGINE IN SUBJE...
Medical condition: Type 1 Diabetes
Disease: Version SOC Term Classification Code Term Level
8.1 10045228 Type I diabetes mellitus LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DK (Prematurely Ended) DE (Prematurely Ended) GB (Prematurely Ended) NL (Completed) IE (Prematurely Ended) AT (Prematurely Ended) FI (Prematurely Ended) FR (Completed) SE (Prematurely Ended) BE (Completed) PT (Prematurely Ended)
Trial results: View results
EudraCT Number: 2006-002576-18 Sponsor Protocol Number: A4061027 Start Date: 2006-11-24
Sponsor Name: Pfizer Ltd.
Full Title: A PHASE 2 STUDY OF THE ANTI-ANGIOGENESIS AGENT AG-013736 IN PATIENTS METASTATIC OR UNRESECTABLE LOCALLY-ADVANCED THYROID CANCER REFRACTORY TO, OR NOT SUITABLE CANDIDATES FOR 131I TREATMENT
Medical condition: Treatment of patients with 131I-refractory metastatic or unresectable locally-advanced papillary, follicular, or Hurthle-cell thyroid cancer who are also refractory to, or intolerant of, or have cl...
Disease: Version SOC Term Classification Code Term Level
8.1 10055107 Thyroid cancer metastatic LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: CZ (Completed) IT (Completed) ES (Completed)
Trial results: View results
EudraCT Number: 2006-003935-56 Sponsor Protocol Number: TMC-CAN-05-03 Start Date: 2006-11-24
Sponsor Name: The Medicines Company
Full Title: A clinical trial comparing treatment with cangrelor (in combination with usual care) to usual care, in subjects who require percutaneous coronary intervention
Medical condition: Subjects with coronary atherosclerosis (excluding ST segment-elevation MI [STEMI]) who require PCI (with or without stent).
Disease: Version SOC Term Classification Code Term Level
8.1 10011093 Coronary atherosclerosis LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: NL (Completed) ES (Ongoing) CZ (Prematurely Ended) LT (Completed) SK (Completed) DE (Prematurely Ended) IT (Completed)
Trial results: View results
EudraCT Number: 2006-002464-26 Sponsor Protocol Number: 2006/175 Start Date: 2006-11-24
Sponsor Name: Vejle Sygehus
Full Title: EFFEKTEN AF VELCADE PÅ KNOGLEVÆVET VED MYELOMATOSE (KNOGLEMARVSKRÆFT).
Medical condition: Multiple myeloma in adults.
Disease: Version SOC Term Classification Code Term Level
8.1 10028228 Multiple myeloma LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DK (Completed)
Trial results: (No results available)
EudraCT Number: 2006-005049-12 Sponsor Protocol Number: RN1002-0066 Start Date: 2006-11-24
Sponsor Name: Renovo Ltd
Full Title: A Double Blind, Placebo Controlled Trial to Investigate the Efficacy of Zesteem in Accelerating the Healing of Split Thickness Skin Graft Donor Sites
Medical condition: Wound Healing
Disease: Version SOC Term Classification Code Term Level
8.1 10036892 Promotion of wound healing LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: LV (Completed) DE (Completed) GB (Completed)
Trial results: (No results available)

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera